Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 25.60
0.00 (0.00%)
Jul 30, 2026, 1:45 PM CST
Diamond Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,016 | 2,504 | 2,707 | 2,416 | 865 | 975 | |
Market Cap Growth | -43.25% | -7.50% | 12.05% | 179.34% | -11.33% | - |
Enterprise Value | 1,040 | 2,548 | 2,785 | 2,686 | 1,023 | 1,086 |
Last Close Price | 25.60 | 63.00 | 67.85 | 65.38 | 23.37 | 26.25 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 36.98 | 51.69 | 25.90 | 23.27 |
PS Ratio | 2.03 | 4.99 | 3.52 | 3.92 | 1.99 | 2.47 |
PB Ratio | 1.88 | 4.62 | 4.35 | 6.97 | 2.86 | 3.57 |
P/TBV Ratio | 1.88 | 4.63 | 4.37 | 7.13 | 2.98 | 3.83 |
P/FCF Ratio | - | - | 269.72 | - | 10.23 | - |
P/OCF Ratio | - | - | 68.88 | 59.06 | 5.49 | 172.78 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.07 | 5.08 | 3.63 | 4.36 | 2.35 | 2.75 |
EV/EBITDA Ratio | - | - | 21.18 | 29.36 | 13.84 | 13.63 |
EV/EBIT Ratio | - | - | 25.71 | 42.03 | 22.14 | 22.67 |
EV/FCF Ratio | - | - | 277.51 | - | 12.10 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.43 | 0.43 | 0.40 | 0.97 | 0.65 | 0.62 |
Debt / EBITDA Ratio | - | - | 1.85 | 2.95 | 1.99 | 1.61 |
Debt / FCF Ratio | - | - | 25.07 | - | 2.33 | - |
Net Debt / Equity Ratio | 0.04 | 0.04 | 0.01 | 0.74 | 0.33 | 0.43 |
Net Debt / EBITDA Ratio | -0.39 | -0.39 | 0.04 | 2.82 | 1.34 | 1.49 |
Net Debt / FCF Ratio | -8.30 | -8.30 | 0.55 | -1.65 | 1.17 | -6.15 |
Asset Turnover | 0.52 | 0.52 | 0.83 | 0.86 | 0.74 | 0.81 |
Inventory Turnover | 2.53 | 2.53 | 4.10 | 4.04 | 2.83 | 2.60 |
Quick Ratio | 2.20 | 2.20 | 2.37 | 1.05 | 0.81 | 1.18 |
Current Ratio | 3.28 | 3.28 | 3.28 | 1.50 | 1.22 | 1.77 |
Return on Equity (ROE) | -12.07% | -12.07% | 15.10% | 14.40% | 11.60% | 16.59% |
Return on Assets (ROA) | -5.58% | -5.58% | 7.30% | 5.59% | 4.93% | 6.12% |
Return on Invested Capital (ROIC) | -15.19% | -14.39% | 13.44% | 10.18% | 9.31% | 11.07% |
Return on Capital Employed (ROCE) | -12.00% | -12.00% | 12.80% | 12.00% | 14.10% | 14.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -6.92% | -2.81% | 2.70% | 1.93% | 3.86% | 4.30% |
FCF Yield | -0.29% | -0.12% | 0.37% | -6.45% | 9.78% | -1.97% |
Dividend Yield | 0.63% | - | 0.29% | 0.21% | 0.36% | 0.40% |
Payout Ratio | - | - | 6.76% | 6.47% | 11.42% | 2.37% |
Buyback Yield / Dilution | -2.19% | -2.19% | -5.33% | -1.02% | 0.00% | -3.35% |
Total Shareholder Return | -1.56% | -2.19% | -5.04% | -0.81% | 0.36% | -2.95% |